FDA files NDI for Lipowheat oil
This article was originally published in The Tan Sheet
Executive SummaryFDA accepts without objection a new dietary ingredient application for Lipowheat oil - giving the developer Hitex tacit approval to market the "all natural vegetable extract" in the U.S., according to an April 4 release. The ingredient is "the only source of natural ceramide on the market with an NDI on file," according to P.L. Thomas, the North American distributor for the ingredient. Ceramides, along with cholesterol and free fatty acids, are the lipids that help bind together the cells of the skin's stratum corneum and play an important role in skin hydration, the company explains. Thomas - and formulators that use the ingredient - claim Lipowheat oil "restores the skin barrier function, ensuring a healthy hydration mechanism." The ingredient can be used in skin-hydrating supplements or drinks supported by clinical trials
You may also be interested in...
A draft guidance document by the US FDA that tackles medical device cybersecurity will likely be issued in the next several months, says Linda Ricci, a health scientist for the agency’s Office of Device Evaluation. Check out her comments on cybersecurity here.
Phase Ib data at ASH look competitive with new pivotal trial results for Bristol/bluebird’s leading BCMA CAR-T bb2121. The Phase II portion of the CARTITUDE-1 study for JNJ-4528 is fully enrolled.